Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: A higher resting heart rate is associated with an increased probability of cardiovascular complications and premature death in patients with type 2 diabetes mellitus. The impact of heart rate on the risk of developing microvascular complications, such as diabetic retinopathy and nephropathy, is, however, unknown. The present study tests the hypothesis that a higher resting heart rate is associated with an increased incidence and a greater progression of microvascular complications in patients with type 2 diabetes mellitus. Methods and Results: The relation between baseline resting heart rate and the development of a major microvascular event was examined in 11 140 patients who participated in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) study. Major microvascular events were defined as a composite of new or worsening nephropathy or new or worsening retinopathy. Patients with a higher baseline heart rate were at increased risk of a new major microvascular complication during follow‐up (adjusted hazard ratio: 1.13 per 10 beats per minute; 95% confidence interval: 1.07–1.20; P <0.001). The excess hazard was evident for both nephropathy (adjusted hazard ratio: 1.16 per 10 beats per minute; 95% confidence interval: 1.08–1.25) and retinopathy (adjusted hazard ratio: 1.11 per 10 beats per minute; 95% confidence interval: 1.02–1.21). Conclusion: Patients with type 2 diabetes mellitus who have a higher resting heart rate experience a greater incidence of new‐onset or progressive nephropathy and retinopathy. Clinical Trial Registration: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00145925. http://www.advance-trial.com/static/html/prehome/prehome.asp
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Similar differential effects of treatment on differing microvascular complications have been observed in other large studies.(42,43) Whether this reflects differing pathophysiological mechanisms, is a chance finding, or is due to the definitions used and the relatively short duration of follow-up is not clear.”
ResultGerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · cited 1×
“M icroalbuminuria and retinopathy are indicators of microvascular dysfunction, and both predict a poorer outcome in patients with diabetes and in individuals with normal glycemic control.(4,5) In particular, even mild degrees of microalbuminuria are a strong and independent predictor of major cardiac events in the gen…”
BackgroundPatel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationIsmail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428 · cited 1×
“Similar differential effects of treatment on differing microvascular complications have been observed in other large studies.(42,43) Whether this reflects differing pathophysiological mechanisms, is a chance finding, or is due to the definitions used and the relatively short duration of follow-up is not clear.”
ResultStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Resting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062 · cited 1×
“Likewise, several studies have reported an association between a higher resting heart rate and an increased risk of cardiovascular complications in unselected populations and in patients with cardiac disease.(9,10) Recently, we reported a similar relation between resting heart rate and all-cause death, cardiovascular…”
BackgroundHeart rate as marker of sympathetic activity
Grassi, G., Vailati, S., Bertinieri, G., Seravalle, G., Stella, M. L., DellʼOro, R., & Mancia, G. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00010 · Cited by 279 · cited 1×
“It is possible, therefore, that the observed relation between heart rate and microvascular events is mediated at least in part by sympathetic overactivity, although correlations between heart rate and measures of sympathetic tone are relatively weak.(36) Whenbaroreflex control of heart rate is assessedby sensitive met…”
BackgroundSelf-citationDu, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp055 · Cited by 239
Self-citation
Cited by
Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease
Böhm, M., Reil, J.-C., Deedwania, P., Kim, J. B., & Borer, J. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.09.016 · Cited by 236
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
Sano, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.12.004 · Cited by 188
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
Lorenz, M., Lawson, F., Owens, D., Raccah, D., Roy-Duval, C., Lehmann, A., Perfetti, R., & Blonde, L. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0490-6 · Cited by 166
Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis
Mann, J. F. E., Buse, J. B., Idorn, T., Leiter, L. A., Pratley, R. E., Rasmussen, S., Vilsbøll, T., Wolthers, B., & Perkovic, V. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14443 · Cited by 120
Self-citationRuggenenti, P., Abbate, M., Ruggiero, B., Rota, S., Trillini, M., Aparicio, C., Parvanova, A., Petrov Iliev, I., Pisanu, G., Perna, A., et al. (2017) · Diabetes · doi:10.2337/db16-0607 · Cited by 95
Metadata
- Authors
- Hillis, G. S., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C. K., Zoungas, S., Patel, A., Poulter, N. R., Mancia, G., Williams, B., & Chalmers, J.
- Venue
- Journal of the American Heart Association
- Published
- 2012-09-26
- Volume
- 1
- Issue
- 5
- Pages
- e002832-e002832
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2111983625
- Cited by
- 68
- References
- 8
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1161/jaha.112.002832
- The paper
- Hillis, G. S., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C. K., Zoungas, S., Patel, A., Poulter, N. R., Mancia, G., Williams, B., & Chalmers, J. (2012). Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus. Journal of the American Heart Association. https://doi.org/10.1161/jaha.112.002832
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.